Back to Search Start Over

Dupixent recommended for EU approval in young children with EoE

Source :
M2 Pharma. September 20, 2024
Publication Year :
2024

Abstract

M2 PHARMA-September 20, 2024-Dupixent recommended for EU approval in young children with EoE (C)2024 M2 COMMUNICATIONS French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) and US-based biotechnology company Regeneron Pharmaceuticals [...]

Subjects

Subjects :
Regeneron Pharmaceuticals Inc.
Euronext Paris S.A.
Sanofi S.A.
Health care industry
Securities industry
Pharmaceutical industry
Health care industry
Securities industry
Chemistry
European Union
Dupixent (Medication)

Details

Language :
English
Database :
Gale General OneFile
Journal :
M2 Pharma
Publication Type :
News
Accession number :
edsgcl.809297568

Tools

Authors Abstract Subjects Details